Combination of Revlimid, Melphalan and Dexamethasone as First Line Treatment for Multiple Myeloma

NCT00843310 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Due to slow accrual

Conditions

Multiple Myeloma

Interventions

DRUG: Lenalidomide (Revlimid)
DRUG: Melphalan
DRUG: Dexamethasone

Sponsor

NYU Langone Health

Collaborators

[object Object]